Boston Scientific (BSX)
(Delayed Data from NYSE)
$81.60 USD
+0.23 (0.28%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $81.64 +0.04 (0.05%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/24/24 |
---|---|
Current Quarter | 0.58 |
EPS Last Quarter | 0.62 |
Last EPS Surprise | 6.90% |
ABR | 1.25 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 2.40 |
Next Year | 2.71 |
EPS (TTM) | 2.23 |
P/E (F1) | 34.02 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 4.03B | 4.25B | 16.26B | 17.95B |
# of Estimates | 10 | 10 | 10 | 10 |
High Estimate | 4.05B | 4.28B | 16.31B | 18.07B |
Low Estimate | 4.02B | 4.20B | 16.20B | 17.73B |
Year ago Sales | 3.53B | 3.73B | 14.24B | 16.26B |
Year over Year Growth Est. | 14.34% | 14.09% | 14.18% | 10.41% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.58 | 0.64 | 2.40 | 2.71 |
# of Estimates | 12 | 10 | 12 | 12 |
Most Recent Consensus | NA | NA | NA | 2.73 |
High Estimate | 0.59 | 0.65 | 2.41 | 2.79 |
Low Estimate | 0.57 | 0.63 | 2.38 | 2.61 |
Year ago EPS | 0.50 | 0.55 | 2.05 | 2.40 |
Year over Year Growth Est. | 16.00% | 16.36% | 17.07% | 12.96% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 1 |
Up Last 30 Days | 0 | 0 | 0 | 1 |
Up Last 60 Days | 9 | 10 | 12 | 12 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.58 | 0.64 | 2.40 | 2.71 |
7 Days Ago | 0.58 | 0.64 | 2.40 | 2.71 |
30 Days Ago | 0.58 | 0.64 | 2.40 | 2.71 |
60 Days Ago | 0.57 | 0.62 | 2.32 | 2.62 |
90 Days Ago | 0.57 | 0.62 | 2.32 | 2.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.58 | 0.64 | 2.40 | 2.73 |
Zacks Consensus Estimate | 0.58 | 0.64 | 2.40 | 2.71 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.75% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.62 | 0.56 | 0.55 | 0.50 | NA |
Estimate | 0.58 | 0.51 | 0.51 | 0.48 | NA |
Difference | 0.04 | 0.05 | 0.04 | 0.02 | 0.04 |
Surprise | 6.90% | 9.80% | 7.84% | 4.17% | 7.18% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more